SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
71.70
+0.20 (0.28%)
May 29, 2026, 1:30 PM CST
Market Cap3.20B -21.5%
Revenue (ttm)1.26B -3.3%
Net Income257.51M -32.5%
EPS5.89 -31.0%
Shares Out 44.59M
PE Ratio12.17
Forward PEn/a
Dividend4.00 (5.58%)
Ex-Dividend DateJul 21, 2025
Volume45,430
Open71.30
Previous Close71.50
Day's Range71.10 - 72.10
52-Week Range70.00 - 90.60
Beta-0.09
Analystsn/a
Price Targetn/a
Earnings DateAug 6, 2026

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulc... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1982
Employees 223
Stock Exchange Taipei Exchange
Ticker Symbol 1777
Full Company Profile

Financial Performance

In 2025, SYN-TECH Chem. & Pharm.'s revenue was 1.30 billion, an increase of 3.39% compared to the previous year's 1.26 billion. Earnings were 261.61 million, a decrease of -33.48%.

Financial Statements